4 Under-the-Radar Stocks With 319% to 645% Upside in 2022, According to Wall StreetThe Motley Fool • 01/29/22
Vaxart Deserves More Respect on Wall Street for Its Promising Covid-19 VaccineInvestorPlace • 12/21/21
VXRT Stock: Other Vaccine Stocks Are Gaining But Jim Cramer Just Sent Vaxart DownInvestorPlace • 12/01/21
Stanford Scientists First To Identify New Cellular Correlates of Protection Against Influenza for an Oral Flu Vaccine Developed by VaxartGlobeNewsWire • 11/18/21
Earnings Preview: VAXART, INC. (VXRT) Q3 Earnings Expected to DeclineZacks Investment Research • 11/04/21
Vaxart Provides Business Update and Reports Third Quarter 2021 Financial ResultsGlobeNewsWire • 11/04/21